|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Evaluation statement: the complaint device is not being returned, therefore is unavailable for a physical evaluation.A batch record review has been conducted to determine if there were any internal processing issues which would have contributed to the nature of the product complaint.Our results indicate that this batch of product was processed without incident and therefore there is no internally assignable cause for the reported problem.Further, a review into the depuy mitek complaints system revealed 1 dissimilar complaint, where the distal tip broke upon insertion, for this lot released to distribution.We cannot discern a root cause for the reported failure mode.At this point in time, no corrective action is required and no further action is warranted.However, depuy mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.(b)(4).This report is being filed from the remetrex complaint management system as required under mitek's corrective and preventative actions (capa) to file usa fda mdr missed malfunctions.
|
|
It was reported by the sales rep that during a rotator cuff repair that the sutures just came loose on the customer's healix br anchor 5.5mm with orthocord when the surgeon pulled them to tie them.The surgeon used the inserted to remove this anchor from the bonehole.The surgeon completed the procedure with another like same size, same type anchor in the same bonehole with no patient consequences or delay.The sales rep reported that the bonehole was prepped with the 5.5 healix awl tap.The sales rep was not present and could not confirm if the anchor had broken but was told it was fully removed and a new anchor inserted into the same bonehole.There was patient involvement reported.There were no injuries, medical intervention or prolonged hospitalization.All available information has been disclosed.If additional information should become available, a supplemental medwatch report will be submitted accordingly.
|